Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sun Pharma ANZ Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (437)
Cancellation by sponsor (155)
Prescription medicine registration (28)
Section 14, TGO91 consent (5)
Australian public assessment report (AusPar) (4)
Prescription medicine decision summary (1)

Date

2025 (39)
2024 (47)
2023 (36)
2022 (54)
2021 (41)
2020 (25)
2019 (26)
2018 (50)
2017 (18)
2016 (35)
2015 (20)
2014 (10)
2013 (22)
2012 (62)
2011 (92)
2010 (14)
2009 (13)
2007 (12)
2006 (10)
2005 (3)

Search

Sponsor content

630 result(s) found, displaying 281 to 290

BOSENTAN RBX bosentan (as monohydrate) 62.5 mg film-coated tablet bottle (257758)

11 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BOSENTAN RBX bosentan (as monohydrate) 62.5 mg film-coated tablet bottle.
BOSENTAN RBX bosentan (as monohydrate) 125 mg film-coated tablet bottle (257756)

11 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BOSENTAN RBX bosentan (as monohydrate) 125 mg film-coated tablet bottle.
BOSENTAN SUN bosentan (as monohydrate) 62.5 mg film-coated tablet blister pack (257755)

11 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BOSENTAN SUN bosentan (as monohydrate) 62.5 mg film-coated tablet blister pack.
BOSENTAN RAN bosentan (as monohydrate) 125 mg film-coated tablet blister pack (257733)

11 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BOSENTAN RAN bosentan (as monohydrate) 125 mg film-coated tablet blister pack.
BOSENTAN SUN bosentan (as monohydrate) 125 mg film-coated tablet blister pack (257752)

11 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BOSENTAN SUN bosentan (as monohydrate) 125 mg film-coated tablet blister pack.
BOSENTAN SUN bosentan (as monohydrate) 125 mg film-coated tablet bottle (257759)

11 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BOSENTAN SUN bosentan (as monohydrate) 125 mg film-coated tablet bottle.
BOSENTAN SUN bosentan (as monohydrate) 62.5 mg film-coated tablet bottle (257760)

11 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BOSENTAN SUN bosentan (as monohydrate) 62.5 mg film-coated tablet bottle.
Pemetrexed SUN pemetrexed (as disodium) 100mg/vial powder for injection vial (233814)

17 June 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Pemetrexed SUN pemetrexed (as disodium) 100mg/vial powder for injection vial.
Pemetrexed SUN pemetrexed (as disodium) 1000mg/vial powder for injection vial (233817)

17 June 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Pemetrexed SUN pemetrexed (as disodium) 1000mg/vial powder for injection vial.
Pemetrexed SUN pemetrexed (as disodium) 500mg/vial powder for injection vial (233816)

17 June 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Pemetrexed SUN pemetrexed (as disodium) 500mg/vial powder for injection vial.

Pages

First page
Previous page
…
Page 25
Page 26
Page 27
Page 28
Current page 29
Page 30
Page 31
Page 32
Page 33
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.